Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Adma Biologics (ADMA) over the last 11 years, with Q3 2025 value amounting to $2.8 million.

  • Adma Biologics' Non-cash Items fell 6272.3% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 6272.3%. This contributed to the annual value of $68.1 million for FY2024, which is 66415.75% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Non-cash Items is $2.8 million, which was down 6272.3% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Non-cash Items registered a high of $68.1 million during Q4 2024, and its lowest value of $35935.0 during Q4 2021.
  • Over the past 5 years, Adma Biologics' median Non-cash Items value was $5.6 million (recorded in 2022), while the average stood at $8.9 million.
  • In the last 5 years, Adma Biologics' Non-cash Items surged by 2116128.29% in 2022 and then tumbled by 6401.05% in 2025.
  • Adma Biologics' Non-cash Items (Quarter) stood at $35935.0 in 2021, then surged by 21161.28% to $7.6 million in 2022, then rose by 16.67% to $8.9 million in 2023, then skyrocketed by 664.16% to $68.1 million in 2024, then crashed by 95.95% to $2.8 million in 2025.
  • Its Non-cash Items stands at $2.8 million for Q3 2025, versus $2.6 million for Q2 2025 and $12.7 million for Q1 2025.